New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells

G. G. Holz

doi:10.1055/s-2005-861314

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2005; 37(2): 126
DOI: 10.1055/s-2005-861314

Erratum

New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells

G. G. Holz¹

¹Department of Physiology and Neuroscience, New York University School of Medicine, USA

Abstract

Full Text

PDF Download

G. Holz. New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells. Horm Metab Res 2004; 36: 787 - 774

1. The author's name must read G. G. Holz, not only G. Holz.

2. On page 788, second column, the first sentence must read: “From the standpoint of its usefulness as a treatment for type 2 diabetes mellitus, the glucose-dependent insulin secretagogue action of GLP-1 is of therapeutic importance.“